IBDEI2M9 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.4)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.4,1384,0)
 ;;=ENCEPHALOPATHY^5^109
 ;;^UTILITY(U,$J,358.4,1385,0)
 ;;=HEADACHE^6^109
 ;;^UTILITY(U,$J,358.4,1386,0)
 ;;=MOVEMENT DISORDERS^8^109
 ;;^UTILITY(U,$J,358.4,1387,0)
 ;;=NEOPLASMS^9^109
 ;;^UTILITY(U,$J,358.4,1388,0)
 ;;=NEURODEGENERATIVE DISEASE^10^109
 ;;^UTILITY(U,$J,358.4,1389,0)
 ;;=OTHER^12^109
 ;;^UTILITY(U,$J,358.4,1390,0)
 ;;=CARDIAC DISORDERS^1^109
 ;;^UTILITY(U,$J,358.4,1391,0)
 ;;=INFLAMMATORY & DEMYELINATING DISEASES^7^109
 ;;^UTILITY(U,$J,358.4,1392,0)
 ;;=NEUROMUSCULAR DISORDERS^11^109
 ;;^UTILITY(U,$J,358.4,1393,0)
 ;;=PAIN^13^109
 ;;^UTILITY(U,$J,358.4,1394,0)
 ;;=SPINAL CONDITIONS^15^109
 ;;^UTILITY(U,$J,358.4,1395,0)
 ;;=SYMPTOMS^16^109
 ;;^UTILITY(U,$J,358.4,1396,0)
 ;;=VISION DISTURBANCES^17^109
 ;;^UTILITY(U,$J,358.4,1397,0)
 ;;=EMG DX^4^109
 ;;^UTILITY(U,$J,358.4,1398,0)
 ;;=ESTABLISHED PATIENT^2^110
 ;;^UTILITY(U,$J,358.4,1399,0)
 ;;=INJECTIONS/MEDICATION^13^111
 ;;^UTILITY(U,$J,358.4,1400,0)
 ;;=OTHER^14^111
 ;;^UTILITY(U,$J,358.4,1401,0)
 ;;=ALLERGY INJECTION^1^111
 ;;^UTILITY(U,$J,358.4,1402,0)
 ;;=INJECTION ADMINISTRATION^12^111
 ;;^UTILITY(U,$J,358.4,1403,0)
 ;;=IMMUNIZATION ADMINISTRATION ^9^111
 ;;^UTILITY(U,$J,358.4,1404,0)
 ;;=CATHETER^3^111
 ;;^UTILITY(U,$J,358.4,1405,0)
 ;;=CATH FLUSHES^4^111
 ;;^UTILITY(U,$J,358.4,1406,0)
 ;;=PFT^15^111
 ;;^UTILITY(U,$J,358.4,1407,0)
 ;;=EKG/HOLTER MONITOR^7^111
 ;;^UTILITY(U,$J,358.4,1408,0)
 ;;=IMMUNIZATIONS^10^111
 ;;^UTILITY(U,$J,358.4,1409,0)
 ;;=INFUSIONS^11^111
 ;;^UTILITY(U,$J,358.4,1410,0)
 ;;=PICC^16^111
 ;;^UTILITY(U,$J,358.4,1411,0)
 ;;=SMOKING CESSATION^17^111
 ;;^UTILITY(U,$J,358.4,1412,0)
 ;;=CHEMO AND OTH COMPLEX DRUGS^5^111
 ;;^UTILITY(U,$J,358.4,1413,0)
 ;;=GLUCOSE MONITORING^8^111
 ;;^UTILITY(U,$J,358.4,1414,0)
 ;;=BLOOD TRANSFUSIONS^2^111
 ;;^UTILITY(U,$J,358.4,1415,0)
 ;;=EDUCATION^6^111
 ;;^UTILITY(U,$J,358.4,1416,0)
 ;;=PRESSURE ULCER^13^112
 ;;^UTILITY(U,$J,358.4,1417,0)
 ;;=SKIN^17^112
 ;;^UTILITY(U,$J,358.4,1418,0)
 ;;=SIGNS AND SYMPTOMS^1^112
 ;;^UTILITY(U,$J,358.4,1419,0)
 ;;=CARDIO/VASCULAR^2^112
 ;;^UTILITY(U,$J,358.4,1420,0)
 ;;=COUNSELING^3^112
 ;;^UTILITY(U,$J,358.4,1421,0)
 ;;=ENDOCRINE,METABOLIC,NUTRITION^4^112
 ;;^UTILITY(U,$J,358.4,1422,0)
 ;;=ENT^5^112
 ;;^UTILITY(U,$J,358.4,1423,0)
 ;;=GASTROINTESTINAL^6^112
 ;;^UTILITY(U,$J,358.4,1424,0)
 ;;=GENITOURINARY & RENAL^7^112
 ;;^UTILITY(U,$J,358.4,1425,0)
 ;;=HEPATITIS^8^112
 ;;^UTILITY(U,$J,358.4,1426,0)
 ;;=IMMUNIZATIONS^9^112
 ;;^UTILITY(U,$J,358.4,1427,0)
 ;;=MUSCULOSKELETAL^10^112
 ;;^UTILITY(U,$J,358.4,1428,0)
 ;;=NEUROLOGY^11^112
 ;;^UTILITY(U,$J,358.4,1429,0)
 ;;=NURSING MISCELLANEOUS^12^112
 ;;^UTILITY(U,$J,358.4,1430,0)
 ;;=PREVENTIVE MEDICINE^14^112
 ;;^UTILITY(U,$J,358.4,1431,0)
 ;;=PULMONARY/RESPIRATORY^15^112
 ;;^UTILITY(U,$J,358.4,1432,0)
 ;;=PSYCHIATRIC^16^112
 ;;^UTILITY(U,$J,358.4,1433,0)
 ;;=OB/GYN PROCEDURES^1^113
 ;;^UTILITY(U,$J,358.4,1434,0)
 ;;=INJECTABLES/IMMUNIZATIONS^5^113
 ;;^UTILITY(U,$J,358.4,1435,0)
 ;;=INJECTION/IMMUNIZATION ADMIN^4^113
 ;;^UTILITY(U,$J,358.4,1436,0)
 ;;=FOREIGN BODY^3^113
 ;;^UTILITY(U,$J,358.4,1437,0)
 ;;=UA/FINGERSTICK^12^113
 ;;^UTILITY(U,$J,358.4,1438,0)
 ;;=FLUSHES^2^113
 ;;^UTILITY(U,$J,358.4,1439,0)
 ;;=OTHER PROCEDURES^7^113
 ;;^UTILITY(U,$J,358.4,1440,0)
 ;;=MATERNAL CARE^6^113
 ;;^UTILITY(U,$J,358.4,1441,0)
 ;;=PREVENTIVE COUNSELING^8^113
 ;;^UTILITY(U,$J,358.4,1442,0)
 ;;=PREVENTIVE-ESTAB PT^9^113
 ;;^UTILITY(U,$J,358.4,1443,0)
 ;;=PREVENTIVE-NEW PT^10^113
 ;;^UTILITY(U,$J,358.4,1444,0)
 ;;=SUPPLIES^11^113
 ;;^UTILITY(U,$J,358.4,1445,0)
 ;;=NEW PATIENT^2^114
